Skip to content

Clinical trials

Completed Afibrinogenemia trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Afibrinogenemia Status: Completed Country / region: United States Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20131
20162
20171
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
CSL Behring1
Grifols Therapeutics LLC1
Nicklaus Children's Hospital f/k/a Miami Children's Hospital1
Octapharma1
University Hospital, Geneva1
University of Utah1
Weill Medical College of Cornell University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Afibrinogenemia7
Hemostatic Disorders2
Anemia1
Heart Defects, Congenital1
Hemorrhage1
Lymphoma, Follicular1
Rubinstein-Taybi Syndrome1
Thrombocytopenia1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.